CAR-T cells are serial killers

OncoImmunology

Volumn 4, Issue 12, 2015, Pages

  Davenport, Alexander J ^a,b,c   Jenkins, Misty R ^a,b   Ritchie, David S ^a,b,c   Prince, H Miles ^a   Trapani, Joseph A ^a,b   Kershaw, Michael H ^a,b   Darcy, Phillip K ^a,b   Neeson, Paul J ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

CAR; serial killing; T cell therapy

Indexed keywords

CHIMERIC ANTIGEN RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN;

ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL THERAPY; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; ENZYME REACTIVATION; HUMAN; IMMUNE RESPONSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VACCINATION;

EID: 84944629935     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2015.1053684     Document Type: Article

References (8)

1. S.A.Grupp, M.Kalos, D.Barrett, R.Aplenc, D.L.Porter, S.R.Rheingold, D.T.Teachey, A.Chew, B.Hauck, J.F.Wright, et al. Chimeric antigen receptor–modified T cells for acute lymphoid leukemia. N Engl J Med 2013; 368:1509-18; PMID:23527958; http://dx.doi.org/10.1056/NEJMoa1215134
2. D.L.Porter, B.L.Levine, M.Kalos, A.Bagg, C.H.June. Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia. N Engl J Med 2011; 365:725-33; PMID:21830940; http://dx.doi.org/10.1056/NEJMoa1103849
3. M.H.Kershaw, J.A.Westwood, P.K.Darcy. Gene-engineered T cells for cancer therapy. Nature Publishing Group 2013; 13:525-41; PMID:23880905
4. S.Kakarla, S.Gottschalk. CAR T cells for solid tumors: armed and ready to go? Cancer J 2014; 20:151-5; PMID:24667962; http://dx.doi.org/10.1097/PPO.0000000000000032
5. A.J.Davenport, M.R.Jenkins, R.S.Cross, C.S.Yong, H.M.Prince, D.S.Ritchie, J.A.Trapani, M.H.Kershaw, P.K.Darcy, P.J.Neeson. CAR-T cells inflict sequential killing of multiple tumor target cells. Cancer Immunol Res 2015; 3:483-94; PMID:25711536
6. J.A.Lopez, O.Susanto, M.R.Jenkins, N.Lukoyanova, V.R.Sutton, R.H.P.Law, A.Johnston, C.H.Bird, P.I.Bird, J.C.Whisstock, et al. Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack. Blood 2013; 121:2659-68; PMID:23377437; http://dx.doi.org/10.1182/blood-2012-07-446146
7. I.Liadi, H.Singh, G.Romain, N.Rey-Villamizar, A.Merouane, J.R.Adolacion, P.Kebriaei, H.Huls, P.Qiu, B.Roysam, et al. Individual motile CD4+ T cells can participate in efficient multi-killing through conjugation to multiple tumor cells. Cancer Immunol Res 2015:1-37; PMID:25568067
8. M.A.Pule, B.Savoldo, G.D.Myers, C.Rossig, H.V.Russell, G.Dotti, M.H.Huls, E.Liu, A.P.Gee, Z.Mei, et al. Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma. Nat Med 2008; 14:1264-70; PMID:18978797; http://dx.doi.org/10.1038/nm.1882